Diarylureas for treating pulmonary hypertension

The present invention relates to a pharmaceutical composition comprising at least one diarylurea compound, optionally in combination with at least one further therapeutic agent, for treating, preventing or managing pulmonary hypertension. Useful combinations include, for example, BAY 43-9006 as a diaryl urea compound.